MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cytori Therapeutics Company Profile (NASDAQ:CYTX)

Consensus Ratings for Cytori Therapeutics (NASDAQ:CYTX) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $48.75 (1,541.41% upside)

Analysts' Ratings History for Cytori Therapeutics (NASDAQ:CYTX)
Show:
DateFirmActionRatingPrice TargetActions
3/31/2016Maxim GroupReiterated RatingBuy$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Roth CapitalInitiated CoverageBuy$22.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Ascendiant Capital MarketsInitiated CoverageBuy$18.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2015LaidlawReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha